RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -82.1% | 23,784 | -64.0% | 0.00% | – |
| Q2 2022 | $56,000 | -73.1% | 66,129 | +75.1% | 0.00% | – |
| Q1 2022 | $208,000 | -22.4% | 37,765 | +151.8% | 0.00% | – |
| Q3 2021 | $268,000 | -78.2% | 15,000 | -70.2% | 0.00% | – |
| Q2 2021 | $1,228,000 | -65.7% | 50,300 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $3,578,000 | +4210.8% | 135,028 | +1130.1% | 0.00% | – |
| Q4 2020 | $83,000 | -46.1% | 10,977 | -64.2% | 0.00% | – |
| Q3 2020 | $154,000 | – | 30,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $13,118,000 | 65.48% |
| Flagship Pioneering Inc. | 38,296,526 | $191,866,000 | 5.30% |
| Abbot Financial Management, Inc. | 563,500 | $2,823,000 | 1.83% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,944,000 | 1.83% |
| Artal Group S.A. | 3,778,913 | $18,932,000 | 0.46% |
| Virtus ETF Advisers LLC | 50,863 | $255,000 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 402,555 | $2,017,000 | 0.02% |
| PDT Partners, LLC | 49,500 | $248,000 | 0.02% |
| Baillie Gifford | 4,273,861 | $21,413,000 | 0.02% |
| Trexquant Investment LP | 36,363 | $182,000 | 0.01% |